Skip to content

argenx SE

US · ARGX #369 by market cap Listed 2017
928.44 -2.08 -0.22%
Live - 5344 symbols - heartbeat 82s ago · 2026-10-08 07:00
Pre-market 793.55 -14.53%
After-hours 928.44 0.00%
Overnight 780.55 -15.93%
Market cap
58.39B
P/B
6.94
EPS
19.57
Reader sentiment Are you bullish or bearish on ARGX?

Anonymous reader poll. Unscientific, not investment advice.

Revenue annual, last 8 years

Margins

Gross margin
89.15%
Operating margin
25.39%
Net margin
31.11%

Income statement

Line item 2018 2019 2020 2021 2022 2023 2024 2025
Revenue 24.57M78.46M------------
Gross profit ----41.24M497.28M381.32M1.11B1.96B3.70B
Selling & admin expenses 31.42M72.15M170.55M305.52M469.92M709.54M1.05B1.36B
Research & development 95.64M220.77M370.89M580.52M663.37M859.49M983.42M1.36B
Operating profit -93.63M-200.11M-480.57M-359.90M-723.92M-420.64M-17.84M1.05B
Pretax profit -75.32M-175.92M-605.35M-399.74M-729.31M-304.50M85.18M1.28B
Tax 908.26K5.29M3.10M8.52M-19.72M-9.44M-747.86M-13.43M
Net profit -76.23M-181.21M-608.46M-408.27M-709.59M-295.05M833.04M1.29B
Basic EPS -2-5-13-8-13-51421
Diluted EPS -2.28-4.69-13.40-7.99-13.05-5.1612.7819.57

Balance sheet

Line item 2018 2019 2020 2021 2022 2023 2024 2025
Total current assets 654.82M1.54B2.06B2.54B2.77B4.12B4.88B6.90B
Cash & ST investments 645.81M1.50B2.00B2.34B2.19B3.18B3.38B4.44B
Inventory 0025.20M109.08M228.35M310.55M407.23M473.53M
Total assets 661.70M1.61B2.28B2.85B3.13B4.54B6.20B8.68B
Total current liabilities 45.82M179.70M328.49M301.24M302.28M422.99M669.92M1.32B
Short-term debt --2.22M3.48M3.51M3.42M4.65M6.53M10.83M
Long-term debt ----------------
Total liabilities 45,828,185.77429,806,000.00605,356,000.00316,050,000.00320,562,000.00444,951,000.00704,239,000.001,359,606,000.00
Total equity 615.87M1.18B1.67B2.53B2.81B4.10B5.50B7.32B
Retained earnings -194.01M-383.48M-991.93M-1.40B-2.11B-2.40B-1.57B-279.77M

Cash flow

Line item 2018 2019 2020 2021 2022 2023 2024 2025
Operating cash flow -61.59M151.63M-398.46M-606.81M-862.81M-420.33M-82.75M685.19M
Depreciation & amortization 563.94K2.43M3.92M5.87M104.34M111.31M17.53M28.10M
Free cash flow -62.37M104.90M-403.60M-728.25M-966.63M-464.14M-151.05M573.51M
Dividends paid ----------------
Stock buybacks / issuance 292.52M755.64M813.19M1.09B760.95M1.20B00
Ending cash balance 321.48M372.16M1.22B1.33B800.74M2.05B1.50B3.49B

Returns & efficiency

Line item 2018 2019 2020 2021 2022 2023 2024 2025
ROE % -14.81-20.36-45.57-19.38-26.54-8.5417.3620.15
ROA % -13.78-16.10-33.44-15.90-23.71-7.6915.5117.36
ROIC % -15.03-20.90-45.21-19.37-27.24-11.0715.0318.07
5-year avg ROE % -26.24-24.76-26.70-22.21-24.71-23.46-15.95-3.39
EBIT margin % -381.01-226.54-1,440.56-80.17-177.02-24.764.0030.88
FCF / sales % --133.04----------13.81
Current ratio 14.298.586.268.449.189.757.295.23
Quick ratio 14.178.536.107.888.178.706.404.62
Debt / assets 0.000.450.420.400.400.440.630.54
LT debt / equity --0.430.370.310.320.370.590.50
Interest coverage ---1,274.91-371.09-363.73-331.56-335.8335.57314.23
Revenue CAGR (3Y) % 48.5771.80-1.90172.5173.64209.8063.92116.25
Net income CAGR (3Y) % ----------------
FCF CAGR (3Y) % --117.17------------

Revenue breakdown most recent period

Business

Product net sales100.00%

Region

United States85.13%
Rest of the World8.25%
Japan4.98%
China1.64%

Quote time 2026-10-08 07:00:18 · For reference only, not investment advice and not tailored to your situation.